PAX8 and acute myeloid leukemia: Immunohistochemistry (IHC) confirmed AML with positive staining for HMB-45 and Melan-A, markers of perivascular epithelioid cell differentiation, and negative staining for CK7 and PAX8, ruling out RCC.